Skip to search boxSkip to navigationSkip to main content

Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury

  • Jianchun Chen
    ,
  • ,
  • Raymond C. Harris(corresponding author)
*Corresponding author for this work
  • Vanderbilt University
    ,
  • Department of Veterans Affairs
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

To determine the role of epidermal growth factor receptor (EGFR) activation in renal functional and structural recovery from acute kidney injury (AKI), we generated mice with a specific EGFR deletion in the renal proximal tubule (EGFRptKO). Ischemia-reperfusion injury markedly activated EGFR in control littermate mice; however, this was inhibited in either the knockout or wild-type mice given erlotinib, a specific EGFR tyrosine kinase inhibitor. Blood urea nitrogen and serum creatinine increased to a comparable level in EGFR ptKO and control mice 24 h after reperfusion, but the subsequent rate of renal function recovery was markedly slowed in the knockout mice. Twenty-four hours after reperfusion, both the knockout and the inhibitor-treated mice had a similar degree of histologic renal injury as control mice, but at day 6 there was minimal evidence of injury in the control mice while both EGFRptKO and erlotinib-treated mice still had persistent proximal tubule dilation, epithelial simplification, and cast formation. Additionally, renal cell proliferation was delayed due to decreased ERK and Akt signaling. Thus, our studies provide both genetic and pharmacologic evidence that proximal tubule EGFR activation plays an important role in the recovery phase after acute kidney injury.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 45-52 (8 pages)

Journal (Volume, Issue Number)

Kidney International (Volume 82, Issue 1)

Publication milestones

  • Published - 07/01/2012

Publication status

Published - 07/01/2012

ISSN

0085-2538

Publication IDs

  • Scopus: 84862787119
  • PubMed: 22418982

Publication metrics

Metrics

SciVal
citations
88
Scopus
citations
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
3.07
SciVal
Author count
3
SciVal
Paper percentile
96
SciVal
Top percentile
5

PlumX, opens in new tab

Citation count
136
Captures
63

Funding Details

This work was supported by funds from the Department of Veterans Affairs and National Institutes of Health Grant No. DK51265, DK62794, and DK7934 to RCH and funds from a Vanderbilt Diabetes Research and Training Center Pilot and Feasibility Grant No. 2P60DK020593, American Heart Association Scientist Development Grant No. 0630274N, and National Institutes of Health R01 Grant No. DK83575 to J-KC.
FundersFunding numbers
NIH
DK51265, DK62794, DK7934
VA
-
AHA
0630274N
DRTC
2P60DK020593